Evidence Based Dermatology
Part I
Diagnosis
1 Studies and Systematic Reviews on Diagnostic Test Accuracy
2 Diagnostic Accuracy of Teledermatology
3 Evidence-Based Patch Testing
4 Diagnosis of Melanoma
5 Diagnosis of Cutaneous T-Cell Lymphoma
6 Diagnostic Criteria for Cutaneous Lupus Erythematosus
7 Diagnosis of Parasitic Skin Diseases
8 Diagnosis of Hirsutism
Part II
Therapy
9 Systematic Review and Meta-Analysis
10 Treatment of Hand Dermatitis
11 Treatment of Acute Urticaria and Angioedema
12 Treatment of Chronic Urticaria
13 Atopic Dermatitis
14 Treatment of Melasma
15 Treatment of Psoriasis
16 Treatment of Lichen Planus
17 Treatment of Pemphigus
18 Treatment of Dystrophic Epidermolysis Bullosa
19 Treatment of Alopecia Areata
20 Treatment of Female Androgenetic Alopecia
21 Treatment of Genital Warts
22 Treatment of Nongenital Warts
23 Treatment of Herpes Simplex
24 Treatment of Herpes Zoster
25 Treatment of Impetigo
26 Treatment of Tinea Capitis
27 Treatment of Tinea Versicolor
28 Treatment of Cutaneous Leishmaniasis
29 Treatment of Head Lice
30 Treatment of Scabies
31 Treatment of Onychomycosis
32 Treatment of Leprosy (Hansen’s Disease)
33 Treatment of Cutaneous Lupus Erythematosus
34 Treatment of Cutaneous Dermatomyositis
35 Treatment of Systemic Sclerosis
36 Treatment of Vitiligo
37 Treatment of Hirsutism (Medical Interventions)
38 Evidence-Based Procedural Dermatology
39 Treatment of Unwanted Hair (Nonmedical Interventions)
40 Tattoo Removal
41 Treatment of Photodamage
42 Chemoprevention of Skin Cancer
43 Treatment of Actinic Keratosis
44 Treatment of Basal Cell Carcinoma
45 Treatment of Cutaneous Squamous Cell Carcinoma
46 Treatment of Cutaneous Melanoma
47 Treatment of Mycosis Fungoides and Sézary Syndrome
48 Treatment of Kaposi’s Sarcoma
49 Treatment of Chronic Wounds
50 Treatment of Venous Leg Ulcers
51 Treatment of Hypertrophic and Keloid Scarring
52 Treatment of Acne (Non-Medical Interventions)
53 Sick Building Syndrome: Cutaneous Manifestations
Part III
Risk Factor Analysis
54 Risk Factors for Nonmelanoma Skin Cancer
55 Risk Factors for Alopecia
56 Risk Factors for Occupational Contact Dermatitis
57 Viral Infections and Skin Cancer
Part IV
Pharmacoepidemiology
58 Principles of Pharmacoepidemiology
59 Azathioprine
60 Imiquimod
61 Topical Tar
62 Biologics
63 Topical Immunomodulators
64 Hypnosis
65 Photodynamic Therapy
66 Skin Substitutes
67 Thalidomide
68 Percutaneous Hormone Transfer
Part V
Cost Effectiveness Studies
69 Cost-effectiveness of Psoriasis Treatments
70 Cost-effectiveness of Rosacea Treatments
71 Cost Effectiveness of Treatment for Non-Melanoma Skin Cancer
Part VI
Evidence Based Approach
72 Adherence to Treatment
73 Ethnic Issues in Evidence-Based Dermatology
74 Dermatoepidemiology and Evidence-based Dermatology Training During Residency
75 Electronic Resources For Evidence-Based Dermatology
Index